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Abstract
Airway stents (silicone and metal stents) are used to treat patients with benign tracheal stenosis,
who are symptomatic and in whom tracheal surgical reconstruction has failed or is not appropriate.
However airway stents are often associated with complications such as migration, granuloma
formation and mucous hypersecretion, which cause significant morbidity, especially in patients with
benign tracheal stenosis and relatively normal life expectancy. We report a patient who had
frequent critical airway obstructions over 8 years due to granuloma and mucus hypersecretion in
a silicone airway stent. The problem was resolved when the silicone stent was removed and
replaced with a covered self expanding metal stent.
Background
Benign tracheal stenosis secondary to prolonged intuba-
tion and/or tracheostomy has been treated by airway
stenting in selected patients1.
There are four categories of airway stents – silicone stents,
balloon-dilated metal stents, self-expanding metal stents
(SEMS) and covered SEMS. There are no randomized con-
trolled trials comparing different stents and each category
has its merits and limitations [1]. The silicone Dumon®
stent (Novatech, Boston Medical, Massachusetts, USA) is
widely popular and often used to treat benign tracheal ste-
nosis. Complications include stent migration, granuloma
formation and mucostatsis [2]. Covered SEMS, such as the
Ultraflex™ stent (Boston Scientific, Massachusetts, USA)
are more biocompatible and some reports suggest fewer
complication rates compared with silicone stents. We
report a patient who developed major complications with
a Dumon® stent which were ameliorated when it was
replaced by an Ultraflex™ stent.
Case report
A 19 year old woman developed Guillain-Barre syndrome
and respiratory failure in 1999, whilst living in a different
city. Prolonged intubation followed by tracheostomy was
complicated by tracheal stenosis. Tracheal reconstruction
surgery was performed but was unsuccessful in maintain-
ing airway patency. Immediately afterwards a 12 mm × 40
mm Dumon® silicone stent was inserted. However this
stent was complicated by frequent obstructions due to
granulation tissue and mucous plugs.
Due to work commitments she relocated to our city in
March 2006. In July 2006 she presented to the emergency
department of our institution with acute dyspnea and stri-
dor. Emergency bronchoscopy revealed extensive granula-
tion tissue and mucous plugging within the Dumon®
stent. Over the next 16 months she had 9 emergency pres-
entations with stent obstructions. Each episode was
resolved with bronchoscopic piecemeal removal of granu-
lation tissue and suctioning of mucus.
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In Nov 2007 she presented with severe respiratory distress
and bronchoscopy revealed that the Dumon® stent had
moved proximally (Figure 1) with granulation tissue in
the distal end (Figure 2) causing 90% obstruction in mid-
trachea. The Dumon® stent was removed and replaced
with a 14 mm × 60 mm Ultraflex™ stent. The new stent
was successful with resolution of tracheal obstruction. The
patient has remained asymptomatic since, with no further
episodes of airway obstruction.
Discussion
Benign tracheal stenosis is most often caused by pro-
longed intubation and/or tracheostomy. 67–90% of
patients who are intubated develop laryngotracheal injury
and 12–14% develop tracheal stenosis [3]. Symptomatic
benign tracheal stenosis is optimally treated by tracheal
reconstruction surgery [4]. However, if this procedure is
medically contraindicated or has failed previously then
prosthetic stents are used to maintain airway patency.
Silicone stents are relatively inexpensive, generally do not
fracture, resist extrinsic compression (e.g. from scar tissue
or tumour) and can be easily repositioned or removed if
required. However stent complications have been
reported to occur in up to 42% of patients [5]. Long-term
complications include migration (17%), granuloma
(6%), and mucostasis causing airway obstruction (6%)
[5]. One study found that 42% of patients require emer-
gency bronchoscopy for stent related complications
within 3 months of stent insertion [6]. Provocation of
local inflammatory reaction results in growth of granula-
tion tissue. Laser resection of in-stent granuloma must be
performed with caution as there have been reports of flash
fire and stent damage [4]. An additional problem with sil-
icone stents is that the ratio of wall thickness to internal
diameter is higher when compared to metal stents result-
ing in a smaller internal diameter in most cases [7]. Sili-
cone stent-specific complications have raised the question
of whether metallic stents might overcome some of these
difficulties.
There has been increasing enthusiasm for using covered
SEMS such as Ultraflex™ stents, which are built from a sin-
gle layer of braided knitted flexible nitinol (nickel-tita-
nium alloy) with an outer covering of silicone [1]. They
have excellent flexibility, good biocompatibility and the
self-expanding force is an important factor that enables
the nitinol mesh to attach directly to the tracheal wall.
While some reports have shown that there are few compli-
cations when SEMS are used to treat benign tracheal sten-
osis [8,9] others have found complications occurring in
52–87% of patients [3,4]. These include granuloma,
mucus retention and stent fracture [3,4]. Such concerns
have prompted the Food and Drug Administration to
publish a cautionary advisory on the use of metallic stents
in patients with benign airway disease [10].
Our report illustrates the complications associated with
silicone airway stents when used to treat benign tracheal
stenosis. Interestingly while the patient had frequent air-
way obstructions with the Dumon® stent, she did not
experience these with the Ultraflex™ stent. Careful patient
selection and recognition of complications is paramount
before considering patients with benign tracheal stenosis
for treatment with prosthetic airway stents.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Silicone tracheal (Dumon®) stent has migrated proximally Figure 1
Silicone tracheal (Dumon®) stent has migrated prox-
imally.
Granulation tissue obstructing distal end of silicone tracheal  (Dumon®) Dumon stent Figure 2
Granulation tissue obstructing distal end of silicone 
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